Targeting Limb Muscle Dysfunction in COPD by Nyberg, Andre & Frykholm, Erik
Selection of our books indexed in the Book Citation Index 
in Web of Science™ Core Collection (BKCI)
Interested in publishing with us? 
Contact book.department@intechopen.com
Numbers displayed above are based on latest data collected. 
For more information visit www.intechopen.com
Open access books available
Countries delivered to Contributors from top 500 universities
International  authors and editors
Our authors are among the
most cited scientists
Downloads
We are IntechOpen,
the world’s leading publisher of
Open Access books
Built by scientists, for scientists
12.2%
122,000 135M
TOP 1%154
4,800
Chapter 8
Targeting Limb Muscle Dysfunction in COPD
Andre Nyberg and Erik Frykholm
Additional information is available at the end of the chapter
http://dx.doi.org/10.5772/intechopen.90815
© 2016 The Author(s). Licensee InTech. This chapter is distributed under the terms of the Creative Commons 
Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, 
distribution, and reproduction in any medium, provided the original work is properly cited. 
r   y r   ri  Fry l
Additional infor ation is available at the end of the chapter
Abstract
Chronic obstructive pulmonary disease (COPD), is today one of the world’s most common 
chronic diseases, estimated by the World Health Organization to be the third leading cause of 
death worldwide by the year 2030. An often neglected aspect of COPD is that the course of the 
disease is linked to extrapulmonary manifestations that are currently not dealt with optimally, 
but that has a direct and substantial impact on the condition. Limb muscle dysfunction, at the 
functional level defined as the reduction of either strength or endurance (or both) properties of 
the muscle, is highly prevalent in COPD, closely linked to critical clinical and prognostic out-
comes including functional status, quality of life, and even mortality. If the goal is to improve 
limb muscle function among people with COPD is exercise training recommended before 
other treatment modalities, highly prioritized in international guidelines. In this chapter, why 
and how to assess and manage limb muscle dysfunction among people with COPD will be 
targeted, highlighting the vital role of physical therapy and the physiotherapist.
Keywords: chronic obstructive pulmonary disease, limb muscle dysfunction, muscle 
strength, muscle endurance, dynamic measurements, static measurements, exercise 
training, resistance training
1. Introduction
Chronic obstructive pulmonary disease (COPD) is one of our most common chronic diseases 
and accounted for 2.6% of the entire global burden of disease 2015 with 63.9 million disability-
adjusted life years. From 1990 to 2015, the prevalence of COPD increased by 44.2% and is now 
estimated to 174.5 million people worldwide [1]. COPD is by the World Health Organization 
anticipated to be the third leading cause of death worldwide by the year 2030.
Although COPD is primarily a disease of the respiratory system, with structural and func-
tional impairments of the lungs [2], the disease is often accompanied by manifestations outside 
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the lungs. One of the most common extrapulmonary manifestations in COPD is limb muscle 
dysfunction, defined as a pathological change of muscle proprieties with a variety of structural 
and morphological abnormalities that compromise the muscle function. The latter evidenced 
by a reduction in the strength and/or endurance capacity of the limb muscles [3], with or with-
out a loss of muscle mass [4]. Limb muscle dysfunction is evident in up to a third of all people 
with COPD and closely linked to the prognosis of the disease. For example, individual factors 
such as reduced mid-thigh cross-sectional area [5], fat-free mass [6], lower quadriceps strength 
[7], and vastus lateralis fiber type shift [8] are all predictors of mortality in COPD. Additionally, 
limb muscle dysfunction is also associated with other important clinical outcomes including 
reduced quality of life [9], reduced exercise tolerance [10–12], and higher healthcare use [13].
Thus, the clinical and prognostic importance of limb muscle dysfunction in COPD stress the 
importance of assessing the limb muscle and develop therapies aiming at stopping or slowing 
down the progression of limb muscle dysfunction, for which the physiotherapist has a crucial 
role. In this chapter, the etiology and pathophysiology of limb muscle dysfunction in people 
with COPD will be briefly overviewed; the main objective is to highlight why and how to 
assess and manage limb muscle dysfunction in people with COPD within the clinical context.
2. Features and importance of limb muscle dysfunction in COPD
Limb muscle dysfunction includes a variety of structural and morphological abnormalities 
within the muscle resulting in muscle atrophy, weakness, and reduced endurance [4, 14]. 
Most studied is the quadriceps muscle, this since the quadriceps muscle is an essential muscle 
for everyday activities such as standing up and walking.
Aspects of limb muscle dysfunction in COPD include larger amounts of intramuscular fat [15] 
effectively reducing the contractile mass within the muscle; mitochondrial dysfunction includ-
ing a reduced absolute and relative number of mitochondria but also a changed oxidative capac-
ity of the mitochondria [16]; and a shift from muscle fiber type I toward fiber type IIx which is 
inconsistent with healthy aging and displays the muscle’s poor ability for aerobic work [17].
The structural changes affect functional capacity with impairments such as reduced oxidative 
capacity and a greater reliance on anaerobic work [18], as well as reduced muscle strength or 
endurance [3, 19]. It should be noted that the structural changes mentioned here apply to the 
quadriceps muscle, and other muscle groups, especially upper limb muscle are not affected 
to the same extent [20]; thus, limb muscle dysfunction is a heterogenic rather than homog-
enous process. Furthermore, physiological responses to activities can be different across limb 
muscles and depending on the type of exercise performed [21–27].
2.1. Etiology and pathophysiology of limb muscle dysfunction
People with COPD are inactive [28], and deconditioning due to disuse seems to play a vital 
role in limb muscle dysfunction. There is, however, evidence to suggest that the limb muscle 
dysfunction is linked to COPD or at least share the same contributing risk factors. Thus, limb 
muscle dysfunction is not as simple as a direct consequence of inactivity and disuse (Figure 1).
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First, when people with COPD are compared to people without COPD but matched with 
equally low physical activity levels, differences in structure and function remain [29]. Second, 
quadriceps weakness occurs already in the early stages of COPD [30] when the reduced 
respiratory capacity should be of minor importance. And third, the training response seems 
blunted on a structural level for people with COPD [31]. Additional systemic factors, including 
tobacco smoking, systemic inflammation, exacerbations, nutrition, gas exchange abnormali-
ties, and drugs, can also influence the function of both respiratory and peripheral muscles, 
by inducing changes in their local microenvironment. Under all these circumstances may, 
protein metabolism imbalance, oxidative stress, inflammatory events, as well as muscle injury 
occur, determining the final structure and modulating the function of different muscle groups. 
For thorough reviews of the pathophysiology, we refer to other sources [4, 32]. Last, the het-
erogeneity of limb muscle dysfunction in COPD emphasizes a need for specificity, which is 
equally true for assessment of the limb muscles as well as concerning therapies. We, therefore, 
present aspects of limb muscle dysfunction separate and do not have a one solution fits all.
2.2. Muscle mass
Muscle mass refers to the amount of muscle available for contractile work and can be reported 
on a whole-body level, a segmental level, the individual muscles, or on a muscle fiber level 
depending on the assessment method. Reduction or loss of muscle mass is the leading cause 
of weight loss within the COPD population [33] and has been demonstrated to be a better 
predictor of health-related quality of life [9] and survival [5] than, for example, body weight 
or Body Mass Index (BMI) [34]. Reduced limb muscle mass over time can be defined as muscle 
wasting and is part of sarcopenia (that is, changes in muscle proprieties due to aging) and 
cachexia (defined as a complex metabolic syndrome associated with underlying illness and 
characterized by loss of muscle with or without loss of fat mass) [35].
Figure 1. Illustration of the complex interplay of factors and outcomes were limb muscle dysfunction playing a role for 
people with COPD, some have been thoroughly studied whereas others have not.
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Fat-free mass is frequently used as a proxy for muscle mass on a whole-body level and is 
usually reported as a fat-free mass index by dividing the fat-free mass by the individual’s 
length in meters squared (fat-free mass/m2). Several criteria have been suggested to define 
low muscle mass, but irrespective of the criteria used, low muscle mass is common in COPD 
[4]. Moreover, a low-fat free mass index has been reported in 26% of patients with COPD 
with a normal BMI [36]. Irrespective of BMI, a low-fat free mass index is a strong predictor of 
mortality [6], and mid-thigh cross-sectional area is a better predictor of mortality than body 
mass index [5]. A fat-free mass index <16 kg/m2 (male) or <15 kg/m2 (female) is linked with 
approximately a twofold increase in mortality among people with COPD [6, 37, 38]. A low-fat 
free mass is also associated to reduced quality of life [9]. Another important notion is that the 
lower limb muscles are particularly vulnerable to the muscle wasting process in COPD [39, 
40], and the loss of thigh muscle mass is relatively more significant than that of whole-body 
weight, indicating a preferential loss of muscle mass in the legs of people with COPD [41].
2.3. Muscle strength
Reduced muscle strength or muscle weakness, defined as the force generated by a specific 
muscle or group of muscles in a single contraction [42], has been found in one-third of people 
with COPD attending hospital respiratory outpatient services [43]. However, when quad-
riceps strength is normalized by thigh muscle cross-sectional area or by muscle mass, the 
difference may no longer be significant [41, 44]. Therefore, the reduced quadriceps strength 
could mostly be a reflection of the loss in muscle mass [40]. This finding is not universal, and 
the weakness is sometimes disproportional to the reduction in muscle mass [43]. A dispro-
portional reduction in quadriceps weakness may occur in individuals with a high dose of oral 
corticosteroids [41]. This may however only apply to individuals treated with a high dose 
of oral corticosteroids over long periods, as no further decrease in quadriceps strength was 
reported in short-term corticosteroid-treated people with COPD compared with untreated 
people with COPD [45]. Reduced limb muscle strength is associated with reduced exercise 
tolerance [10, 11], mortality [7], and higher healthcare use [13].
2.4. Muscle endurance
Quadriceps muscle strength and quadriceps muscle endurance are both reduced in people 
with COPD. However, quadriceps muscle endurance, defined as the ability to maintain or 
repeat a contraction over time [42], might be more reduced than quadriceps strength. For 
example, quadriceps muscle endurance has been reported to be reduced with up to 82% 
among men and up to 76% among women compared to matched people without COPD, 
while quadriceps muscle strength was decreased with 29 and 19% among men and women, 
respectively [3]. Furthermore, using a non-volitional approach with a magnetic nerve stimu-
lator strapped around the quadriceps muscle, people with COPD had approximately 45% 
of the muscle endurance capacity of people without COPD [46]. However, the variability 
between studies is vast, and it is probably due to differences in test procedures since quad-
riceps muscle endurance has been assessed in numerous ways [19]. Limb muscle endurance 
is essential for work tolerance over time, and it has been shown that people with COPD rate 
leg fatigue higher than dyspnea in exercise tests [47]. Quadriceps endurance also seems to be 
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closer related to functional tests such as the 6-minute walk test than the quadriceps strength 
[48–50], implicating importance for performing daily activities. Contradictory to quadriceps 
strength, quadriceps endurance to muscle mass ratio is lower in people with COPD compared 
to people without COPD [51], and people with COPD, regardless of fat-free mass, have a 
higher degree of fatigue during endurance tests compared to people without COPD [52]. 
Most studies have been conducted in a population of severe COPD, but the reduced quadri-
ceps muscle endurance is also evident in people with mild to moderate COPD [53].
2.5. In summary
3. How to assess limb muscles in clinical practice
Assessment of limb muscle mass and function should always be a priority within clinical 
praxis of COPD management, due to its clinical and prognostic relevance [4, 54, 55].
Considering the complexity of limb muscle dysfunction in COPD, no single test could be used 
to assess and monitor all aspects of the limb muscles within the COPD population, resulting 
in a wide range of available tests and measurement techniques [14, 54–56].
When deciding on how to assess limb muscles in clinical practice, several factors should be 
considered and will influence the choice of technique and strategy used. Table 1 highlights 
some factors that physiotherapists need to take into account when making this decision [55].
For example, among people with COPD, assessment of limb muscle mass and function should 
always include the quadriceps muscle due to its clinical and prognostic value [4, 7]; however, 
as all assessments are muscle group-specific, other limb muscles may also be assessed to pro-
vide valuable information [4].
Furthermore, the availability of measurement equipment will likely vary between clinical set-
tings and contexts, thus impacting the choice of the assessment strategy. The physiotherapist 
needs to acknowledge that measurement equipment and assessment strategies are not inter-
changeable and may provide different information even if the goal of the assessment would 
be the same [55, 57].
Different assessment strategies might also vary concerning important quality aspects, includ-
ing but not limited to validity, reliability, and responsiveness. For example, test–retest reli-
ability is of importance to consider when performing assessments before and after exercise 
Limb muscle dysfunction encompasses several manifestations including, muscle atrophy and weakness, reduced 
endurance, and susceptibility to muscle fatigue, which reflects both structural and morphological muscle adapta-
tions that are seen in limb muscles among people with COPD.
Limb muscle dysfunction is evident in up to a third of all individuals with COPD and has a direct and substantial 
impact on the condition. For example, limb muscle dysfunction is intimately linked to relevant clinical outcomes, 
including physical activity, exercise tolerance, quality of life, healthcare use, and even survival.
Thus, limb muscle dysfunction is an essential area for physical therapy and should be prioritized among 
physiotherapists.
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interventions to interpret findings [57–61], while validity, for example, could be an issue when 
using simple field tests to provide information on aspects of limb muscle function [62–65].
Irrespective of the goal of the measurement technique used, standardization plays a 
crucial role to increase the measurement quality when assessing limb muscles in COPD, 
including standardization of preparation guidelines (e.g., guidelines for medications, caf-
feine, activities, etc. before an assessment), equipment (e.g., free weight/weight-machines/
dynamometers), instructions (e.g., written/oral/visual), familiarization (to minimize learn-
ing effect), warm-up (e.g., general vs. specific warm-up of targeted muscles), positioning, 
the range-of-motion (e.g., start and end positions), velocity (e.g., seconds in concentric/
eccentric phase of movement), and rest (between contractions/sets, etc.). For further details 
on what to consider to standardize assessments, we refer to previously published work 
[42, 54, 55].
Nevertheless, irrespective of all factors to consider when deciding on how to assess limb 
muscles in clinical practice, the take-home message is that the limb muscles should be evalu-
ated. Despite the prognostic and clinical relevance of limb muscle dysfunction in people 
with COPD, and even though assessment of limb muscles is recommended in international 
guidelines [4], it remains to be an integrated part of the routine evaluation and management 
of COPD.
3.1. Muscle mass
Assessing only BMI is inadequate to quantify the impact of COPD on different muscle com-
partments or to provide valid information on muscle mass [36] since BMI does not give any 
information on body composition or fat distribution [54]. Instead, fat-free mass could be tar-
geted and is frequently used as a proxy for muscle mass on a whole-body level among people 
with COPD [4].
• What is the aim of the measurement?
For example, diagnostic purposes? Evaluation purposes?
• Which muscle(s) should we target?
For example, upper extremity/lower extremity, unilateral/bilateral, one/several muscle(s).
• Which aspect(s)?
For example, muscle mass, strength, endurance, fatigue, power, etc.
• Which type(s) of muscle contraction?
For example, static/dynamic concentric/eccentric, volitional/non-volitional.
• Which equipment?
For example, weight-machines/free-weights, elastic/functional, availability.
• Measurements quality.
For example, validity, reliability, accessibility, feasibility, responsiveness.
Table 1. Factors to consider when deciding on how to assess limb muscles [53].
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The gold standard and reference method in COPD for assessing fat-free mass is through 
determining total body water by deuterium dilution [66]; however, this technique is invasive, 
and use of the method is likely limited to research centers [56]. Fat-free mass could also be 
assessed using simple techniques such as skinfold anthropometry. However, this technique 
generally overestimates the fat-free mass when compared to other techniques, especially if 
measured on more obese individuals [67, 68].
Two techniques that are realistic to be used in the clinical environment to monitor and provide 
accurate assessments of fat-free mass in COPD are bioelectrical impedance (BIA) and dual-energy 
X-ray absorption (DEXA). Both techniques are noninvasive and have shown to provide valid and 
reliable information on the distribution of fat-free mass among people with COPD [7, 67, 69–71]. 
BIA has the advantage of being less expensive and often more easily accessible than DEXA in 
clinical settings [69]. When estimating fat-free mass from BIA, it is vital to use equations that have 
been validated within the COPD population and to be cautious with built-in equations provided 
by manufacturers [72, 73]. Also of importance is that since BIA is influenced by total body water, 
fluid balance and time of day need to be controlled, primarily when a longitudinal assessment 
is performed. For example, if used as an outcome measure after an exercise training period [54]. 
About the latter, it should be noted that even though BIA (and DEXA) assessments could provide 
information for body compartments (e.g., left/right arm, trunk, left/right leg), these techniques 
might be less sensitive to change than if direct assessments of regional muscle mass using more 
advanced techniques such as computed tomography, magnetic resonance, or ultrasound imag-
ing are performed [27, 74]. Furthermore, the correlation between local and whole-body muscle 
mass is weak in COPD, thus suggesting that direct assessment of regional muscle mass indeed 
has additional value [74]. Nevertheless, as availability of different measurement equipment 
likely varies between clinical settings, it is important to note that, except BMI measurements, 
all techniques listed above theoretically could be used to assess muscle mass in people with 
COPD. However, the physiotherapist needs to acknowledge and take into account the advan-
tages and disadvantages of each technique when performing the assessment.
3.2. Muscle strength
Assessment of limb muscle strength could be done in numerous ways using both volitional 
(effort dependent) and non-volitional (independent from the patient’s motivation and effort) 
techniques. Both techniques provide valid and reliable results independent of disease sever-
ity [58, 59, 65, 75]. Even though non-volitional assessments of muscle strength could be per-
formed through electrical or magnetic stimulation of the muscle or its motor nerve [76], these 
non-volitional techniques are in a similar way as assessing total body water by deuterium 
dilution (to determine muscle mass), mainly limited to research centers and clinical research 
[14]. Non-volitional assessments are also rarely used within COPD research to assess the effect 
of exercise interventions over time [26]. Thus, voluntary, effort dependent maneuvers, is the 
most clinically feasible way of measuring limb muscle strength in people with COPD [77].
Limb muscle strength measurements could be performed using various devices and tech-
niques, including strain gauges, handheld or fixed portable dynamometers, weight machines, 
or manual muscle testing techniques as well as more complex systems such as computerized 
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dynamometers [78, 79]. Furthermore, such assessments could be performed using static (iso-
metric), or by using dynamic (isotonic [fixed external loading] or isokinetic [fixed speed of 
movement]) techniques (Table 2).
To date, static measurements of quadriceps muscle strength have been put forward and 
recommended, as they provide essential prognostic information [7]. Static measurements of 
grip strength have also been used among people with COPD; however, current research is 
contradictory, and grip strength does not appear to be associated with disease severity or to 
be decreased more than among the general older population [80], even though this is not a 
universal finding [81]. Even though static measurements of quadriceps muscle strength is rec-
ommended, recent literature suggests that dynamic measures of limb muscle strength should 
not be neglected as the dynamic capacity of the muscle seems to be more closely related to 
factors associated with functional tasks, such as walking or standing up from a chair, than 
isometric (static) measurements [49, 79].
Thus, the decision on how to assess muscle strength should be dependent on the clinical 
question we would like to answer.
3.3. Muscle endurance and fatigue
Assessment of limb muscle endurance could in a similar way as limb muscle strength mea-
surements were performed using both volitional and non-volitional techniques, with the 
former being the most clinically feasible. In COPD, direct measures of limb muscle endurance 
have primarily targeted the quadriceps muscle using sustained (isometric) or repeated (iso-
kinetic/isotonic) contractions [19], providing reliable results [57].
However, as the endurance capacity of the limb muscles reflect the ability to perform tasks 
requiring a low number of contractions such as climbing a set of stairs as well as tasks requir-
ing a high number of contractions such as bicycling or walking over a long distance, it is 
apparent that the same method cannot be used to evaluate muscle performance in both situa-
tions and that no single test can evaluate all aspects of limb muscle endurance [19].
Isometric* Isokinetic† Isotonic†
Strength Performing 3–5 MVC held 
for ~5 s, spaced with 30–60s 
rest periods at a fixed 
position.
Performing a minimum of 
3–5 maximal contractions 
at an angular velocity of 
60°–90°s
Performing a 1 RM test following 
ACMS guidelines with the addition 
of standardized range-of-motion and 
speed of contraction
Endurance Sustained contraction at an 
intensity equal to 20–60% of 
isometric MVC until failure 
using visual feedback
Total work obtained from 
(typically 30) maximal 
contractions at an angular 
velocity of 60°–90°s
A maximum number of repetitions 
performed using external loads 
corresponding to 10% up to 50% of the 
individual 1 RM until failure.
MVC, maximal voluntary contraction; ACSM, American college of sports medicine; RM, repetition maximum.
*Normally 60°–90° flexion.
†Normally 90° flexion to full extension.
Table 2. Commonly used procedures for assessment of quadriceps muscle strength and endurance among people with 
COPD [19, 55, 58, 61, 79, 82].
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Thus, to date, there is no specific recommendation on how to assess limb muscle endurance 
among people with COPD, and a vast variation of techniques and strategies have been used, 
including both static and dynamic measurements [19]. Similarly, as for limb muscle strength 
assessments, dynamic measurements of quadriceps endurance seem to be more closely 
related functional tasks than isometric measurements [49].
Furthermore, in comparison to limb muscle strength, the endurance capacity of the limb 
muscles does also seem to be more closely associated with both upper and lower limb func-
tional capacity among people with COPD [50], highlighting one reason for why the endur-
ance capacity of should not be neglected when assessing the limb muscles. For an example of 
commonly used procedures for quadriceps muscle testing see Table 2.
3.4. Functional testing
In the assessment of limb muscles in people with COPD, the use of functional tests is quickly 
becoming more and more popular. One key advantage of using functional tests is that they 
are often cheap, time-efficient, and require minimal equipment and usually a limited amount 
of space. Furthermore, as there is more to limb muscle function in COPD other than strictly 
the ability to exert a specific torque over a particular period of time [55], functional tests 
may provide valuable information that cannot be obtained from direct measurements of limb 
muscle function or mass.
Several different functional tests have been used in people with COPD, with field walking tests 
and different versions of the sit to stand test, being the most common in recent years [62, 83].
Similarly, as for direct measurements of limb muscle mass and function, different functional 
tests provide various information depending on which test is used, and the physiotherapist is 
required to use different tests depending on the objective of the assessment.
Furthermore, the physiotherapist should keep in mind that functional tests and limb muscle 
function assessments evaluate different constructs (as evident by low to moderate associa-
tions between limb muscle function assessments and functional tests), and thus cannot replace 
another [49, 79, 84]. Therefore, when deciding on how to assess the limb muscles in COPD, the 
objective should always be the driving factor.
3.5. In summary
Assessment of limb muscle mass and function should be part of the routine management of people with COPD. One 
aspect that sometimes is overlooked is the complexity, a wide variety of assessment methods could be used for this 
purpose.
Examples from this chapter include muscle mass assessed on whole-body level [6] or by a thin slice of the thigh 
[5], quadriceps strength, and endurance that could be measured static [43] or dynamic [40], resulting in somewhat 
different conclusions dependent on the type of assessment performed. As such, several factors need to be taken 
into account by the physiotherapist when deciding on how to assess limb muscle mass and function in COPD (see 
Table 1 for further details).
Nevertheless, standardization of testing procedures is of utmost importance to provide accurate and reliable assess-
ments, irrespective of measurement technique used.
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4. How to improve limb muscles among people with COPD?
Strategies aiming at stopping or slowing down the progression of limb muscle dysfunction 
are highly warranted, and interventions focusing on exercise training, nutritional supplemen-
tation, and medication alone, or in combination, have all been shown to improve various 
aspects of limb muscle function and mass in people with COPD [4]. The focus in this section 
will be on the use of exercise training, this since exercise training is recommended before all 
other available modalities or combination of modalities [4].
4.1. Exercise training
In one sense, exercise training interventions for people with COPD are no different than for 
other populations; the same general exercise principles (specificity, progression, reversibility, 
periodization, etc.) and acute program variables (choice of exercise, order of exercise order, 
intensity [duration], number of sets, rest period lengths, type of muscle action, speed of move-
ment, volume, frequency, etc.) apply [85–87]. However, for people with COPD, some of these 
variables might need to be altered to maximize benefits [88].
Considering the complexity of limb muscle dysfunction in COPD, no single exercise regimen 
could be used to target all aspects of the decreased function and altered structure of limb mus-
cles [4, 26]. In a recent review, the effects of different modalities including aerobic or resistance 
training, high-intensity interval training, electric or magnetic muscle stimulation, whole-body 
vibration, and water-based exercise modalities to improve limb muscle function and mass 
among people with COPD were summarized. Overall, limb muscle strength was increased in 
78%, limb muscle endurance in 92%, and muscle mass in 88% of the cases where that specific 
aspect of the limb muscle was measured [26] using these different modalities. On average, this 
corresponded to a mean increase in limb muscle strength of 15–34%, limb muscle endurance 
of 8.7–96.6%, and limb muscle mass of 4.2–12.1% and was highly dependent on which type 
of assessment strategy used. For limb muscle strength and endurance, isotonic assessment 
strategies seemed to be most responsive while for muscle mass, direct measurements using 
ultrasound demonstrated the most substantial adaptations, independent of exercise modality 
used [26]. However, there is considerable heterogeneity in the type of exercise modalities 
used, and it is currently unknown which type of exercise modality that is most effective in 
different subgroups of people with COPD. To date, several different exercise modalities are 
available for people with COPD including but not limited to resistance training (strength or 
endurance targeted), aerobic training (continuous or interval), whole body vibration training, 
neuromuscular electrical stimulation, active mind body therapies (e.g., Tai Chi, Qigong, etc.), 
as well as using different strategies to structure (e.g., nonlinear periodization) or to perform 
(e.g., single limb) exercises [21–25, 89]. Nevertheless, the most commonly used approaches are 
aerobic and resistance exercises, and in the design of both modalities for people with COPD, 
the American College of Sports Medicine frameworks [85, 86] has been recommended [88]. 
However, even though both continuous and interval training have shown positive effects of 
limb muscle function and mass in people with COPD, if the aim is to increase these aspects of 
the limb muscles in COPD, resistance training may be a more effective modality than aerobic 
exercises [90–93].
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More significant effects on muscle strength have been observed after resistance training in 
comparison to aerobic training alone or when resistance training is added to an aerobic train-
ing protocol [88, 91, 93]. This fits with the specificity principle of exercise, that is, that exercise 
adaptation is specific to the type of activity and the volume and intensity of the activity per-
formed [86, 94]. However, this also means that different kinds of resistance training protocols 
are necessary to target various aspects of limb muscle dysfunction. For example, if the goal is 
to improve limb muscle strength and mass, high-load/low-repetition programs are favorable 
[92, 95, 96], while if the goal is to enhance limb muscle endurance, low-load/high-repetition 
programs should be used [86, 96, 97]. In addition to decreased limb muscle mass and function, 
limb muscle dysfunction in COPD is also characterized by altered intramuscular character-
istic, that is, structural and muscle metabolic alterations on the functional level result in the 
decreased function of limb muscles in COPD [4, 31]. Thus, of importance is that exercise-
based training interventions also result in both structural and metabolic changes within the 
limb muscles [31], including, but not limited to, changes in fiber type proportion, fiber size, 
capillary to fiber ratio, muscle protein turnover regulation, and mitochondrial enzyme activ-
ity, while markers of oxidative and nitrosative stress and inflammation does not seem to be 
affected [31]. However, in a similar way as for effects on muscle mass and function, exercise 
responses are heterogeneous, dependent on the type and intensity of the activity performed. 
Alterations in fiber proportion, fiber size, and capillary to fiber ratio tend to increase more 
after combined aerobic and resistance training, but predominantly with excellent results after 
higher intensity interval training [31]. Thus suggesting that the intensity of the activity per-
formed is of importance to achieve intramuscular adaptations, even though this needs to be 
confirmed in future studies.
4.2. In summary
5. Conclusions
Limb muscle dysfunction is a highly prevalent and clinically relevant manifestation of COPD, 
closely linked to important clinical outcomes, including exercise tolerance, quality of life, and 
survival. Limb muscle dysfunction seems to be heterogeneous, with the lower limbs, and the 
quadriceps muscle in particular, mostly affected.
Assessment of limb muscle mass and function should be routinely performed in clinical 
practice, and simple valid and reliable tools are available for the physiotherapist to use. 
Exercise training, and resistance training in particular, is the most efficacious approach to ameliorate limb muscle 
dysfunction among people with COPD, with the latter resulting in the most substantial improvements in limb mus-
cle mass and function. However, COPD limb muscle is characterized by a large heterogeneity of muscle phenotypes 
and muscle dysfunction, stressing the importance of identifying those specific factors that should be considered 
in the development of individualized resistance training programs among people with COPD. Thus, no single 
intervention is sufficient to target all aspects of limb muscle dysfunction in the disease. To achieve intramuscular 
adaptations, exercise intensity seems to be an important factor, and high intensity interval training seems to be the 
most promising approach. Lastly, irrespective of exercise training modality, general exercise principles and acute 
program variables should always be incorporated when designing the exercise program.
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Independent of measurement strategy, standardization of measurement properties are cru-
cial and several different factors such as type of contraction, choice of exercise or equipment 
need to be acknowledged by the physiotherapist when deciding on how to assess the limb 
muscles among people with COPD.
Lastly, to improve limb muscle mass and function, exercise training, and resistance training in 
particular is recommended before other available modalities, and general exercise principles and 
acute program variables should always be incorporated into the design of the exercise program.
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